Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

Cherkizovo invests in reconstruction of poultry farms in Bashkiria ₽3 billion

8/18/23 GCHE

Walmart reported for 6 months of fiscal year 2024

8/17/23 WMT

Board of Directors of Cherkizovo recommended that dividends be paid for 6 months 2023

8/17/23 GCHE

Cian expects to close its acquisition of SmartDeal by the end of the year

8/17/23 CIAN

Cherkizovo reported 6 months of 2023 by IFRS

8/17/23 GCHE

Rosgosstrakh reported for 6 months of 2023 by IFRS

8/17/23 RGSS

En+ Group reported for 6 months of 2023 by IFRS

8/17/23 ENPG

Issuers hope for extension of moratorium on delisting of quasi-Russian securities

8/17/23 MOEX

Cisco reported for fiscal year 2023

8/17/23 CSCO

Qiwi assessed the impact of the Bank of Russia's restrictions on its business

8/17/23 QIWI